Mint essential oils for inhibition HRASQ61L mutant keratinocyte activity and prevention skin carcinogenesis
Publish time: 2022-11-03 00:00:00
Mint essential oils for inhibition HRASQ61L mutant keratinocyte activity and prevention skin carcinogenesis
Docket Number
14A-1070831
IP Status
TWI 759633、US 11872260 B2
Abstract
This invention discloses the applications and usages of a special Mentha species and its essential oil chemical constituents for skin-related applications and chemical prevention. The biofunctions and applications of the special mint essential oil include: anti-inflammation, inhibition of melanin formation, skin cancer prevention, and alleviating cutaneous side effects induced by targeted therapy in human patients.
Technological Advantages
- Effectively inhibit or prevent targeted therapy drug (like BRAF inhibitor vemurafenib) induced-cutaneous squamous cell carcinoma.
- Established the chemical constituents and appropriate ratio of specialized mint essential oils for chemistry, manufacturing, and controls (CMC) of product quality.
- Applicable to topical application and easy to develop as a commercial product.
- Established GAP of the specialized Mentha plant species which can be stable source plant materials for commercialization purposes.
Applications of Technology
- A therapeutic option/drug, healthy food, botanical supplement or nutraceutical for chemoprevention, alleviating or reduction of cutaneous side effects induced by cancer therapeutic drugs.
- A healthy food, botanical supplement, or nutraceutical for anti-inflammation, skin whitening, etc.
Inventor
Lie-Fen Shyur, Chih-Ting Chang, Yu-Hsin Chen
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Mint essential oils for inhibition HRASQ61L mutant keratinocyte activity and prevention skin carcinogenesis